✦ LIBER ✦

Modulation of CD3-zeta as a marker of clinical response to IL-2 therapy in ovarian cancer patients

✍ Scribed by Douglas D Taylor; Robert P Edwards; Catherine R Case; Çiçek Gerçel-Taylor

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Her-2/neu as a Predictive Marker of Resp

✍ Mark D. Pegram; Giovanni Pauletti; Dennis J. Slamon 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 926 KB

Early response to antipsychotic therapy

✍ Virginia L. Stauffer; Michael Case; Bruce J. Kinon; Robert Conley; Haya Ascher-S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 345 KB

BRCA1promoter methylation is a marker of

✍ Ignatov, T.; Eggemann, H.; Costa, S. D.; Roessner, A.; Kalinski, T.; Ignatov, A. 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 349 KB

Spermidine/spermine N1-acetyltransferase

✍ Jun Li; Heather M. Wallace 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 106 KB

1141 Clinical Use of HER2 Extracellular

✍ Kontani, K.; Hashimoto, S.; Murazawa, C.; Ohtani, M.; Date, M.; Yamauchi, A.; Yo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Interleukin-2 dose, blood monocyte and C

✍ Gregers G. Hermann; Poul F. Geertsen; Hans von der Maase; Jesper Zeuthen 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 583 KB